Fangrong Zhang
Changsha, 410000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exosomal tRF-1003 induces angiogenesis via regulating the HIF1α/VEGF signaling in multiple myeloma.
Journal: International immunopharmacology
Published: September 24, 2024
N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair.
Journal: Frontiers in cell and developmental biology
Published: February 07, 2024
POEMS syndrome in the 21st century: A bibliometric analysis.
Journal: Heliyon
Published: July 03, 2023
The selective activator protein-1 inhibitor T-5224 regulates the IRF4/MYC axis and exerts cooperative antimyeloma activity with bortezomib.
Journal: Chemico-biological interactions
Published: April 19, 2023
CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma.
Journal: International journal of pharmaceutics
Published: March 11, 2023
tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma.
Journal: BMC bioinformatics
Published: January 02, 2021
Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis.
Journal: International journal of medical sciences
Published: April 08, 2020
Bortezomib-inducible long non-coding RNA myocardial infarction associated transcript is an oncogene in multiple myeloma that suppresses miR-29b.
Journal: Cell death & disease
Published: January 31, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026